{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T07:04:20Z","timestamp":1791097460212,"version":"4.1.0"},"reference-count":16,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1754,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1111\/j.1365-2362.2010.02415.x","type":"journal-article","created":{"date-parts":[[2010,11,12]],"date-time":"2010-11-12T07:52:25Z","timestamp":1289548345000},"page":"343-348","source":"Crossref","is-referenced-by-count":38,"title":["Pneumocystis jirovecii colonization in patients treated with infliximab"],"prefix":"10.1111","volume":"41","author":[{"given":"Gustavo","family":"Wissmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rub\u00e9n","family":"Morilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Mart\u00edn-Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Friaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nieves","family":"Respaldiza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Povedano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"Praena-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco A.","family":"Montes-Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"Medrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano Z.","family":"Goldani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"de la Horra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Varela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique J.","family":"Calder\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,11,12]]},"reference":[{"key":"10.1111\/j.1365-2362.2010.02415.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1078\/1434-4610-00107","article-title":"Historical perspective on Pneumocystis carinii infection","volume":"153","author":"Calderon-Sandubete","year":"2002","journal-title":"Protist"},{"key":"10.1111\/j.1365-2362.2010.02415.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"34S","DOI":"10.1186\/ar552","article-title":"Emerging role of anti-tumor necrosis factor therapy in rheumatic diseases","volume":"4","author":"Kalden","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1111\/j.1365-2362.2010.02415.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s10620-006-9250-x","article-title":"Pneumocystis jiroveci (carinii) pneumonia after infliximab therapy: a review of 84 cases","volume":"52","author":"Kaur","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1111\/j.1365-2362.2010.02415.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/ard.2007.072967","article-title":"Post-marketing surveillance of the safety profile of infliximab in 5,000 Japanese patients with rheumatoid arthritis","volume":"67","author":"Takeuchi","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2362.2010.02415.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1056\/NEJMc070728","article-title":"Pneumocystis pneumonia associated with Infliximab in Japan","volume":"357","author":"Harigai","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2362.2010.02415.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1111\/j.1550-7408.2006.00188.x","article-title":"Usefulness of Oropharyngeal Washings for identifying Pneumocystis jirovecii carriers","volume":"53","author":"Respaldiza","year":"2006","journal-title":"J Eukaryot Microbiol"},{"key":"10.1111\/j.1365-2362.2010.02415.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s10165-008-0037-0","article-title":"Asymptomatic carriage of Pneumocystis jiroveci in elderly patients with rheumatoid arthritis in Japan: a possible association between colonization and development of Pneumocystis jiroveci pneumonia during low-dose MTX therapy","volume":"18","author":"Mori","year":"2008","journal-title":"Mod Rheumatol"},{"key":"10.1111\/j.1365-2362.2010.02415.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1086\/421778","article-title":"Pneumocystis jiroveci genotypes in the Spanish population","volume":"39","author":"Montes-Cano","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1365-2362.2010.02415.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1128\/IAI.60.4.1279-1284.1992","article-title":"Importance of endogenous tumor necrosis factor alpha and gamma interferon in host resistance against Pneumocystis carinii infection","volume":"60","author":"Chen","year":"1992","journal-title":"Infect Immun"},{"key":"10.1111\/j.1365-2362.2010.02415.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/ibd.20261","article-title":"Prophylaxis against Pneumocystis pneumonia in patients with inflammatory bowel disease: toward a standard of care","volume":"14","author":"Poppers","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1111\/j.1365-2362.2010.02415.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/rheumatology\/keh071","article-title":"Detection of Pneumocystis carinii by DNA amplification in patients with connective tissue diseases: re-evaluation of clinical features of P.\u00a0carinii pneumonia in rheumatic diseases","volume":"43","author":"Saito","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/j.1365-2362.2010.02415.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1086\/523814","article-title":"Epidemiology and clinical significance of Pneumocystis colonization","volume":"197","author":"Morris","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1365-2362.2010.02415.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.mycmed.2009.08.001","article-title":"Epidemiology of Pneumocystis infection in human","volume":"19","author":"Calderon","year":"2009","journal-title":"J Mycol Med"},{"key":"10.1111\/j.1365-2362.2010.02415.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1574-695X.1998.tb01201.x","article-title":"Animal models of pneumocystosis","volume":"22","author":"Dei-Cas","year":"1998","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1111\/j.1365-2362.2010.02415.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/00007890-199209000-00016","article-title":"Comparison of DNA amplification and immunofluorescence for detecting Pneumocystis carinii in patients receiving immunosuppressive therapy","volume":"54","author":"Leigh","year":"1992","journal-title":"Transplantation"},{"key":"10.1111\/j.1365-2362.2010.02415.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/ibd.20519","article-title":"Prevention of Pneumocystis pneumonia in patients with inflammatory bowel disease based on the detection of Pneumocystis colonization","volume":"14","author":"Wissmann","year":"2008","journal-title":"Inflamm Bowel Dis"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2362.2010.02415.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2362.2010.02415.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T20:24:51Z","timestamp":1625343891000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2362.2010.02415.x"}},"subtitle":["INFLIXIMAB AND PNEUMOCYSTIS COLONIZATION"],"short-title":[],"issued":{"date-parts":[[2010,11,12]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2362.2010.02415.x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.8649963.9153061","asserted-by":"object"}]},"ISSN":["0014-2972"],"issn-type":[{"value":"0014-2972","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11,12]]}}}